

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | plasma membrane repair (GO:0001778) | 8.39164749 |
| 2 | actin filament-based movement (GO:0030048) | 8.30474396 |
| 3 | skeletal muscle adaptation (GO:0043501) | 7.93606560 |
| 4 | skeletal muscle fiber development (GO:0048741) | 7.76341325 |
| 5 | sarcomere organization (GO:0045214) | 7.68940249 |
| 6 | * striated muscle contraction (GO:0006941) | 6.87244823 |
| 7 | myotube cell development (GO:0014904) | 6.82722359 |
| 8 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.81317147 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.73026857 |
| 10 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.47261380 |
| 11 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.02075889 |
| 12 | skeletal muscle tissue regeneration (GO:0043403) | 5.99662891 |
| 13 | * myofibril assembly (GO:0030239) | 5.89814868 |
| 14 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.85885427 |
| 15 | response to inactivity (GO:0014854) | 5.80767745 |
| 16 | striated muscle atrophy (GO:0014891) | 5.73622081 |
| 17 | regulation of cell communication by electrical coupling (GO:0010649) | 5.67722388 |
| 18 | cytidine metabolic process (GO:0046087) | 5.67279402 |
| 19 | cytidine catabolic process (GO:0006216) | 5.67279402 |
| 20 | cytidine deamination (GO:0009972) | 5.67279402 |
| 21 | * muscle contraction (GO:0006936) | 5.57641016 |
| 22 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.46519257 |
| 23 | response to muscle activity (GO:0014850) | 5.34915146 |
| 24 | regulation of relaxation of muscle (GO:1901077) | 5.33376114 |
| 25 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.10823684 |
| 26 | muscle atrophy (GO:0014889) | 5.10301652 |
| 27 | muscle fiber development (GO:0048747) | 5.08193108 |
| 28 | * actomyosin structure organization (GO:0031032) | 5.07737946 |
| 29 | * muscle system process (GO:0003012) | 5.02567913 |
| 30 | cardiac myofibril assembly (GO:0055003) | 5.02033426 |
| 31 | striated muscle adaptation (GO:0014888) | 5.01400204 |
| 32 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.99258864 |
| 33 | creatine metabolic process (GO:0006600) | 4.97606469 |
| 34 | carnitine shuttle (GO:0006853) | 4.96136855 |
| 35 | cardiac muscle contraction (GO:0060048) | 4.79109918 |
| 36 | glycogen catabolic process (GO:0005980) | 4.75653419 |
| 37 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.49879363 |
| 38 | glucan catabolic process (GO:0009251) | 4.42575506 |
| 39 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.39598416 |
| 40 | glycogen biosynthetic process (GO:0005978) | 4.32437944 |
| 41 | glucan biosynthetic process (GO:0009250) | 4.32437944 |
| 42 | striated muscle cell development (GO:0055002) | 4.28460766 |
| 43 | negative regulation of muscle hypertrophy (GO:0014741) | 4.25860954 |
| 44 | muscle cell fate commitment (GO:0042693) | 4.21370911 |
| 45 | muscle cell cellular homeostasis (GO:0046716) | 4.19759949 |
| 46 | muscle organ development (GO:0007517) | 4.19627777 |
| 47 | positive regulation of myotube differentiation (GO:0010831) | 4.18423585 |
| 48 | NADH metabolic process (GO:0006734) | 4.17233540 |
| 49 | cellular polysaccharide catabolic process (GO:0044247) | 4.16111998 |
| 50 | muscle adaptation (GO:0043500) | 4.14826872 |
| 51 | muscle structure development (GO:0061061) | 4.12197370 |
| 52 | fatty acid transmembrane transport (GO:1902001) | 4.12162904 |
| 53 | heart process (GO:0003015) | 4.11397553 |
| 54 | heart contraction (GO:0060047) | 4.11397553 |
| 55 | cardiac muscle cell development (GO:0055013) | 4.09817138 |
| 56 | skeletal muscle tissue development (GO:0007519) | 4.08612085 |
| 57 | tricarboxylic acid cycle (GO:0006099) | 4.07700656 |
| 58 | regulation of striated muscle contraction (GO:0006942) | 4.01025942 |
| 59 | muscle hypertrophy (GO:0014896) | 4.00294935 |
| 60 | regulation of sarcomere organization (GO:0060297) | 3.99848304 |
| 61 | polysaccharide catabolic process (GO:0000272) | 3.99423550 |
| 62 | regulation of coenzyme metabolic process (GO:0051196) | 3.98265340 |
| 63 | regulation of cofactor metabolic process (GO:0051193) | 3.98265340 |
| 64 | cardiac cell development (GO:0055006) | 3.83985187 |
| 65 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.81575738 |
| 66 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.79652564 |
| 67 | purine nucleotide salvage (GO:0032261) | 3.73376381 |
| 68 | myotube differentiation (GO:0014902) | 3.73126870 |
| 69 | regulation of actin filament-based movement (GO:1903115) | 3.71736317 |
| 70 | adult heart development (GO:0007512) | 3.69236857 |
| 71 | myoblast fusion (GO:0007520) | 3.65979525 |
| 72 | striated muscle tissue development (GO:0014706) | 3.64628163 |
| 73 | muscle cell development (GO:0055001) | 3.64261029 |
| 74 | IMP metabolic process (GO:0046040) | 3.64172602 |
| 75 | positive regulation of myoblast differentiation (GO:0045663) | 3.62403299 |
| 76 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.60257205 |
| 77 | carnitine transmembrane transport (GO:1902603) | 3.59219029 |
| 78 | striated muscle hypertrophy (GO:0014897) | 3.55030069 |
| 79 | ubiquinone biosynthetic process (GO:0006744) | 3.53068898 |
| 80 | quinone biosynthetic process (GO:1901663) | 3.53068898 |
| 81 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.52684750 |
| 82 | negative regulation of protein localization to cell surface (GO:2000009) | 3.52546485 |
| 83 | regulation of membrane repolarization (GO:0060306) | 3.51770646 |
| 84 | muscle organ morphogenesis (GO:0048644) | 3.50411834 |
| 85 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.49930672 |
| 86 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.49930672 |
| 87 | cardiac muscle hypertrophy (GO:0003300) | 3.48582060 |
| 88 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.41397541 |
| 89 | glycogen metabolic process (GO:0005977) | 3.38118078 |
| 90 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.37176144 |
| 91 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.36771139 |
| 92 | regulation of muscle system process (GO:0090257) | 3.36608308 |
| 93 | regulation of sulfur metabolic process (GO:0042762) | 3.35926368 |
| 94 | muscle tissue morphogenesis (GO:0060415) | 3.33787484 |
| 95 | response to activity (GO:0014823) | 3.31822774 |
| 96 | glucan metabolic process (GO:0044042) | 3.30532557 |
| 97 | cellular glucan metabolic process (GO:0006073) | 3.30532557 |
| 98 | 2-oxoglutarate metabolic process (GO:0006103) | 3.28834115 |
| 99 | fructose metabolic process (GO:0006000) | 3.27524562 |
| 100 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.26643562 |
| 101 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.25653720 |
| 102 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.24895800 |
| 103 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.24895800 |
| 104 | cardiac muscle adaptation (GO:0014887) | 3.23717691 |
| 105 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.23717691 |
| 106 | muscle hypertrophy in response to stress (GO:0003299) | 3.23717691 |
| 107 | syncytium formation (GO:0006949) | 3.23627359 |
| 108 | gluconeogenesis (GO:0006094) | 3.22757270 |
| 109 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.22166795 |
| 110 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.21602078 |
| 111 | muscle tissue development (GO:0060537) | 3.20957328 |
| 112 | regulation of the force of heart contraction (GO:0002026) | 3.18380472 |
| 113 | positive regulation of cation channel activity (GO:2001259) | 3.12250961 |
| 114 | regulation of muscle contraction (GO:0006937) | 3.11844363 |
| 115 | negative regulation of muscle contraction (GO:0045932) | 3.04881970 |
| 116 | muscle filament sliding (GO:0030049) | 13.5327964 |
| 117 | actin-myosin filament sliding (GO:0033275) | 13.5327964 |
| 118 | regulation of skeletal muscle contraction (GO:0014819) | 11.6403867 |
| 119 | skeletal muscle contraction (GO:0003009) | 11.3939064 |
| 120 | actin-mediated cell contraction (GO:0070252) | 11.2385065 |
| 121 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.1052939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.49599095 |
| 2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 5.21809258 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.83182483 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.41163340 |
| 5 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 4.21932150 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.30201415 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.27370406 |
| 8 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.17631075 |
| 9 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.17631075 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.89848335 |
| 11 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.86453779 |
| 12 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.81169430 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.77016744 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.58246778 |
| 15 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.37731658 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.30594859 |
| 17 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.27410178 |
| 18 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.27103512 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.24451339 |
| 20 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.19376584 |
| 21 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.18389316 |
| 22 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.08863918 |
| 23 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.88398488 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.75872786 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.72415636 |
| 26 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.69945667 |
| 27 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.55168144 |
| 28 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.53012493 |
| 29 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.51642780 |
| 30 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.51574249 |
| 31 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50814323 |
| 32 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.47646305 |
| 33 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.46600821 |
| 34 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.43107379 |
| 35 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.38835272 |
| 36 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.36518613 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36462989 |
| 38 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.35806789 |
| 39 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.35496119 |
| 40 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.34184073 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33984953 |
| 42 | CJUN_26792858_Chip-Seq_BT549_Human | 1.33016574 |
| 43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31919066 |
| 44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.31494363 |
| 45 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.29177612 |
| 46 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.27229406 |
| 47 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.27166399 |
| 48 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.24475523 |
| 49 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.22430753 |
| 50 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.22350018 |
| 51 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.20849280 |
| 52 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.18941640 |
| 53 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.16971056 |
| 54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.16368097 |
| 55 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.15050641 |
| 56 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.14217468 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14149163 |
| 58 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.13573888 |
| 59 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.11268168 |
| 60 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.11169772 |
| 61 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.08184873 |
| 62 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06977600 |
| 63 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.06313450 |
| 64 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.06233665 |
| 65 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05251161 |
| 66 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.04994161 |
| 67 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.03958219 |
| 68 | SA1_27219007_Chip-Seq_Bcells_Human | 1.03554289 |
| 69 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.03479873 |
| 70 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.03136998 |
| 71 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.01738539 |
| 72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00959638 |
| 73 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00959638 |
| 74 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.00928136 |
| 75 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.00704264 |
| 76 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00193907 |
| 77 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.99483111 |
| 78 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.98715858 |
| 79 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.98140133 |
| 80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96111472 |
| 81 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95907119 |
| 82 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.95891134 |
| 83 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.95110420 |
| 84 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.94738343 |
| 85 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.94529822 |
| 86 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94434393 |
| 87 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.94303988 |
| 88 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.94138780 |
| 89 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92556482 |
| 90 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.92478281 |
| 91 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.92218635 |
| 92 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.90501178 |
| 93 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.90288584 |
| 94 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.89398415 |
| 95 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89257045 |
| 96 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.88927831 |
| 97 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.88169376 |
| 98 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.87398809 |
| 99 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.86979115 |
| 100 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.86957070 |
| 101 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.86116827 |
| 102 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85502516 |
| 103 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.84825200 |
| 104 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.84821381 |
| 105 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.84557049 |
| 106 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.83995181 |
| 107 | P68_20966046_ChIP-Seq_HELA_Human | 0.82950131 |
| 108 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.82885216 |
| 109 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.82488708 |
| 110 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.82488708 |
| 111 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.82033668 |
| 112 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.81980655 |
| 113 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.81229236 |
| 114 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.80852519 |
| 115 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.80813739 |
| 116 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.80558712 |
| 117 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.80210341 |
| 118 | VDR_22108803_ChIP-Seq_LS180_Human | 0.79032977 |
| 119 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.78347202 |
| 120 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.78275236 |
| 121 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.78257912 |
| 122 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.78037147 |
| 123 | CBP_21632823_ChIP-Seq_H3396_Human | 0.77415813 |
| 124 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.77306060 |
| 125 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.77279605 |
| 126 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76934081 |
| 127 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.75957368 |
| 128 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.75951179 |
| 129 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.75751892 |
| 130 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.75662445 |
| 131 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.75135108 |
| 132 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.75109170 |
| 133 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.75100634 |
| 134 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.74378568 |
| 135 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.74202850 |
| 136 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.74184835 |
| 137 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.74108160 |
| 138 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.74093363 |
| 139 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.73538503 |
| 140 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.73452699 |
| 141 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.73233060 |
| 142 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.73216064 |
| 143 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73199562 |
| 144 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.72269081 |
| 145 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.71934633 |
| 146 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.71246895 |
| 147 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.71186898 |
| 148 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.69634255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 6.64104594 |
| 2 | MP0000749_muscle_degeneration | 6.55311718 |
| 3 | MP0003646_muscle_fatigue | 6.16599189 |
| 4 | MP0000751_myopathy | 5.99740498 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 4.36437440 |
| 6 | MP0002106_abnormal_muscle_physiology | 4.17462511 |
| 7 | MP0000747_muscle_weakness | 4.13406609 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.94761979 |
| 9 | MP0000759_abnormal_skeletal_muscle | 3.65182941 |
| 10 | MP0000750_abnormal_muscle_regeneration | 3.61930901 |
| 11 | MP0004087_abnormal_muscle_fiber | 3.61341906 |
| 12 | MP0005369_muscle_phenotype | 3.50945970 |
| 13 | MP0002269_muscular_atrophy | 3.39712299 |
| 14 | MP0005620_abnormal_muscle_contractility | 3.16167058 |
| 15 | MP0004084_abnormal_cardiac_muscle | 2.85317278 |
| 16 | MP0004130_abnormal_muscle_cell | 2.74276415 |
| 17 | MP0005330_cardiomyopathy | 2.68347165 |
| 18 | MP0000733_abnormal_muscle_development | 2.59765166 |
| 19 | MP0004215_abnormal_myocardial_fiber | 2.40796234 |
| 20 | MP0004233_abnormal_muscle_weight | 2.15797078 |
| 21 | MP0002108_abnormal_muscle_morphology | 2.07427676 |
| 22 | MP0002332_abnormal_exercise_endurance | 1.95366659 |
| 23 | MP0004484_altered_response_of | 1.94913839 |
| 24 | MP0002972_abnormal_cardiac_muscle | 1.94611373 |
| 25 | MP0003950_abnormal_plasma_membrane | 1.87882911 |
| 26 | MP0006036_abnormal_mitochondrial_physio | 1.79217114 |
| 27 | MP0010630_abnormal_cardiac_muscle | 1.67188390 |
| 28 | MP0003137_abnormal_impulse_conducting | 1.38314172 |
| 29 | MP0001544_abnormal_cardiovascular_syste | 1.35747134 |
| 30 | MP0005385_cardiovascular_system_phenoty | 1.35747134 |
| 31 | MP0003221_abnormal_cardiomyocyte_apopto | 1.25271824 |
| 32 | MP0002971_abnormal_brown_adipose | 1.22808679 |
| 33 | MP0005666_abnormal_adipose_tissue | 1.18684478 |
| 34 | MP0005275_abnormal_skin_tensile | 1.18644142 |
| 35 | MP0001661_extended_life_span | 1.18398644 |
| 36 | MP0004185_abnormal_adipocyte_glucose | 1.09931117 |
| 37 | MP0008775_abnormal_heart_ventricle | 1.06427220 |
| 38 | MP0004270_analgesia | 1.04320676 |
| 39 | MP0003828_pulmonary_edema | 1.01817323 |
| 40 | MP0005670_abnormal_white_adipose | 1.00324587 |
| 41 | MP0002127_abnormal_cardiovascular_syste | 0.95962318 |
| 42 | MP0002234_abnormal_pharynx_morphology | 0.95946272 |
| 43 | MP0006138_congestive_heart_failure | 0.94263439 |
| 44 | MP0000013_abnormal_adipose_tissue | 0.92852016 |
| 45 | MP0005266_abnormal_metabolism | 0.91583022 |
| 46 | MP0005375_adipose_tissue_phenotype | 0.90096300 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 0.87750568 |
| 48 | MP0002822_catalepsy | 0.86519029 |
| 49 | MP0006035_abnormal_mitochondrial_morpho | 0.85597812 |
| 50 | MP0000762_abnormal_tongue_morphology | 0.83622678 |
| 51 | MP0004510_myositis | 0.83354531 |
| 52 | MP0003567_abnormal_fetal_cardiomyocyte | 0.76987413 |
| 53 | MP0000372_irregular_coat_pigmentation | 0.74601906 |
| 54 | MP0004147_increased_porphyrin_level | 0.72320473 |
| 55 | MP0000343_altered_response_to | 0.70105258 |
| 56 | MP0000266_abnormal_heart_morphology | 0.68707269 |
| 57 | MP0000579_abnormal_nail_morphology | 0.67325622 |
| 58 | MP0004085_abnormal_heartbeat | 0.67312440 |
| 59 | MP0003941_abnormal_skin_development | 0.66386852 |
| 60 | MP0005451_abnormal_body_composition | 0.66110757 |
| 61 | MP0009250_abnormal_appendicular_skeleto | 0.62733851 |
| 62 | MP0003879_abnormal_hair_cell | 0.62412635 |
| 63 | MP0005503_abnormal_tendon_morphology | 0.61409211 |
| 64 | MP0004134_abnormal_chest_morphology | 0.54197387 |
| 65 | MP0000003_abnormal_adipose_tissue | 0.52459763 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 0.51625376 |
| 67 | MP0003045_fibrosis | 0.46681266 |
| 68 | MP0002734_abnormal_mechanical_nocicepti | 0.46137158 |
| 69 | MP0008438_abnormal_cutaneous_collagen | 0.43792611 |
| 70 | MP0004043_abnormal_pH_regulation | 0.42157507 |
| 71 | MP0005334_abnormal_fat_pad | 0.41973246 |
| 72 | MP0003705_abnormal_hypodermis_morpholog | 0.40050960 |
| 73 | MP0004142_abnormal_muscle_tone | 0.39881320 |
| 74 | MP0002114_abnormal_axial_skeleton | 0.39267730 |
| 75 | MP0002796_impaired_skin_barrier | 0.38710168 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 0.38623848 |
| 77 | MP0003948_abnormal_gas_homeostasis | 0.37333177 |
| 78 | MP0001299_abnormal_eye_distance/ | 0.36099207 |
| 79 | MP0005452_abnormal_adipose_tissue | 0.33853549 |
| 80 | MP0005165_increased_susceptibility_to | 0.33530364 |
| 81 | MP0006276_abnormal_autonomic_nervous | 0.33284209 |
| 82 | MP0002128_abnormal_blood_circulation | 0.30989075 |
| 83 | MP0005166_decreased_susceptibility_to | 0.30447809 |
| 84 | MP0002896_abnormal_bone_mineralization | 0.30059940 |
| 85 | MP0001346_abnormal_lacrimal_gland | 0.29890124 |
| 86 | MP0000230_abnormal_systemic_arterial | 0.29859776 |
| 87 | MP0009115_abnormal_fat_cell | 0.29425875 |
| 88 | MP0000383_abnormal_hair_follicle | 0.29295625 |
| 89 | MP0005376_homeostasis/metabolism_phenot | 0.29217403 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 0.29004587 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.28951110 |
| 92 | MP0001879_abnormal_lymphatic_vessel | 0.28468426 |
| 93 | MP0003385_abnormal_body_wall | 0.28285988 |
| 94 | MP0005187_abnormal_penis_morphology | 0.27821334 |
| 95 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.27272586 |
| 96 | MP0005535_abnormal_body_temperature | 0.26743863 |
| 97 | MP0000767_abnormal_smooth_muscle | 0.26654069 |
| 98 | MP0002638_abnormal_pupillary_reflex | 0.25591000 |
| 99 | MP0001853_heart_inflammation | 0.24575553 |
| 100 | MP0005423_abnormal_somatic_nervous | 0.24493921 |
| 101 | MP0001542_abnormal_bone_strength | 0.24366514 |
| 102 | MP0003656_abnormal_erythrocyte_physiolo | 0.23601431 |
| 103 | MP0003755_abnormal_palate_morphology | 0.22981168 |
| 104 | MP0000678_abnormal_parathyroid_gland | 0.22763376 |
| 105 | MP0002249_abnormal_larynx_morphology | 0.22232166 |
| 106 | MP0010030_abnormal_orbit_morphology | 0.21595135 |
| 107 | MP0008569_lethality_at_weaning | 0.20875600 |
| 108 | MP0002060_abnormal_skin_morphology | 0.20845426 |
| 109 | MP0005501_abnormal_skin_physiology | 0.20766148 |
| 110 | MP0005083_abnormal_biliary_tract | 0.20621810 |
| 111 | MP0004272_abnormal_basement_membrane | 0.20311176 |
| 112 | MP0000534_abnormal_ureter_morphology | 0.20299860 |
| 113 | MP0009672_abnormal_birth_weight | 0.19774146 |
| 114 | MP0001243_abnormal_dermal_layer | 0.19700626 |
| 115 | MP0003279_aneurysm | 0.19428185 |
| 116 | MP0004858_abnormal_nervous_system | 0.19037509 |
| 117 | MP0003195_calcinosis | 0.18304755 |
| 118 | MP0002066_abnormal_motor_capabilities/c | 0.18006498 |
| 119 | MP0003566_abnormal_cell_adhesion | 0.17826972 |
| 120 | MP0001943_abnormal_respiration | 0.17734246 |
| 121 | MP0004197_abnormal_fetal_growth/weight/ | 0.17254047 |
| 122 | MP0001784_abnormal_fluid_regulation | 0.16063557 |
| 123 | MP0002877_abnormal_melanocyte_morpholog | 0.15653072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.85364644 |
| 2 | Nemaline bodies (HP:0003798) | 9.40476306 |
| 3 | Type 1 muscle fiber predominance (HP:0003803) | 7.83179958 |
| 4 | Exercise-induced myalgia (HP:0003738) | 7.57401551 |
| 5 | Distal arthrogryposis (HP:0005684) | 7.53367339 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 6.78104987 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.39384803 |
| 8 | Myopathic facies (HP:0002058) | 6.20122489 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 6.11008662 |
| 10 | Round ear (HP:0100830) | 5.81791241 |
| 11 | Ulnar deviation of the wrist (HP:0003049) | 5.67233067 |
| 12 | Muscle fiber splitting (HP:0003555) | 5.58247912 |
| 13 | Calcaneovalgus deformity (HP:0001848) | 5.14863400 |
| 14 | Difficulty running (HP:0009046) | 4.82751217 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 4.81710080 |
| 16 | Deformed tarsal bones (HP:0008119) | 4.72751597 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 4.66583296 |
| 18 | Abnormality of the calf musculature (HP:0001430) | 4.57756763 |
| 19 | Absent phalangeal crease (HP:0006109) | 4.53605737 |
| 20 | Myoglobinuria (HP:0002913) | 4.48031573 |
| 21 | Increased connective tissue (HP:0009025) | 4.30143345 |
| 22 | Malignant hyperthermia (HP:0002047) | 3.91250960 |
| 23 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.86364386 |
| 24 | Neck muscle weakness (HP:0000467) | 3.85129173 |
| 25 | Muscle stiffness (HP:0003552) | 3.80658059 |
| 26 | Rhabdomyolysis (HP:0003201) | 3.78878449 |
| 27 | Abnormal finger flexion creases (HP:0006143) | 3.78285623 |
| 28 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.74523858 |
| 29 | Subaortic stenosis (HP:0001682) | 3.74523858 |
| 30 | Myotonia (HP:0002486) | 3.56186822 |
| 31 | Sudden death (HP:0001699) | 3.49399143 |
| 32 | Difficulty climbing stairs (HP:0003551) | 3.38788690 |
| 33 | Rimmed vacuoles (HP:0003805) | 3.37490688 |
| 34 | Increased variability in muscle fiber diameter (HP:0003557) | 3.29367457 |
| 35 | Areflexia of lower limbs (HP:0002522) | 3.21535747 |
| 36 | Frequent falls (HP:0002359) | 3.21373697 |
| 37 | Abnormality of the neuromuscular junction (HP:0003398) | 3.18787765 |
| 38 | Fatigable weakness (HP:0003473) | 3.18787765 |
| 39 | Abnormality of the calcaneus (HP:0008364) | 3.02731063 |
| 40 | Distal lower limb muscle weakness (HP:0009053) | 2.97987762 |
| 41 | Bulbar palsy (HP:0001283) | 2.88550804 |
| 42 | Weak cry (HP:0001612) | 2.83140571 |
| 43 | Asymmetric septal hypertrophy (HP:0001670) | 2.76034051 |
| 44 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.74543769 |
| 45 | Slender build (HP:0001533) | 2.74161157 |
| 46 | Generalized muscle weakness (HP:0003324) | 2.69153219 |
| 47 | Ventricular tachycardia (HP:0004756) | 2.65774525 |
| 48 | Gowers sign (HP:0003391) | 2.60558552 |
| 49 | Pelvic girdle muscle weakness (HP:0003749) | 2.55857208 |
| 50 | Shoulder girdle muscle weakness (HP:0003547) | 2.54186690 |
| 51 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.49120013 |
| 52 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.49120013 |
| 53 | Type 2 muscle fiber atrophy (HP:0003554) | 2.47999206 |
| 54 | EMG: neuropathic changes (HP:0003445) | 2.46760103 |
| 55 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.45362071 |
| 56 | Spinal rigidity (HP:0003306) | 2.42168085 |
| 57 | Progressive muscle weakness (HP:0003323) | 2.36484494 |
| 58 | Distal lower limb amyotrophy (HP:0008944) | 2.35315869 |
| 59 | Facial diplegia (HP:0001349) | 2.35074325 |
| 60 | Hyperkalemia (HP:0002153) | 2.34152033 |
| 61 | Hip contracture (HP:0003273) | 2.25952483 |
| 62 | Scapular winging (HP:0003691) | 2.22551041 |
| 63 | Muscular dystrophy (HP:0003560) | 2.22422024 |
| 64 | Popliteal pterygium (HP:0009756) | 2.19185056 |
| 65 | Muscle fiber atrophy (HP:0100295) | 2.18833510 |
| 66 | Lipoatrophy (HP:0100578) | 2.18685783 |
| 67 | Proximal amyotrophy (HP:0007126) | 2.14187753 |
| 68 | Dilated cardiomyopathy (HP:0001644) | 2.11602398 |
| 69 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.05521680 |
| 70 | Hypoplastic ischia (HP:0003175) | 2.05477905 |
| 71 | Nonprogressive disorder (HP:0003680) | 2.04632974 |
| 72 | Right ventricular cardiomyopathy (HP:0011663) | 2.03125253 |
| 73 | Muscle fiber inclusion bodies (HP:0100299) | 10.2020362 |
| 74 | Metatarsus adductus (HP:0001840) | 1.97526501 |
| 75 | Paralysis (HP:0003470) | 1.96378720 |
| 76 | Limb-girdle muscle weakness (HP:0003325) | 1.96218892 |
| 77 | Bundle branch block (HP:0011710) | 1.95160982 |
| 78 | Limb-girdle muscle atrophy (HP:0003797) | 1.92140256 |
| 79 | Waddling gait (HP:0002515) | 1.83773752 |
| 80 | Abnormality of the foot musculature (HP:0001436) | 1.83597798 |
| 81 | Abnormality of placental membranes (HP:0011409) | 1.83329775 |
| 82 | Amniotic constriction ring (HP:0009775) | 1.83329775 |
| 83 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.81891383 |
| 84 | Easy fatigability (HP:0003388) | 1.79220893 |
| 85 | Long clavicles (HP:0000890) | 1.77871012 |
| 86 | Abnormality of the ischium (HP:0003174) | 1.77064982 |
| 87 | Ulnar deviation of finger (HP:0009465) | 1.75273997 |
| 88 | Trismus (HP:0000211) | 1.73751435 |
| 89 | * Fetal akinesia sequence (HP:0001989) | 1.73037877 |
| 90 | Foot dorsiflexor weakness (HP:0009027) | 1.71864512 |
| 91 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.70520793 |
| 92 | Atrial fibrillation (HP:0005110) | 1.70485825 |
| 93 | Lower limb amyotrophy (HP:0007210) | 1.69207776 |
| 94 | Aplasia of the musculature (HP:0100854) | 1.67679040 |
| 95 | Ventricular arrhythmia (HP:0004308) | 1.60578947 |
| 96 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.60302348 |
| 97 | Limited hip movement (HP:0008800) | 1.57792292 |
| 98 | Heart block (HP:0012722) | 1.56780199 |
| 99 | Primary atrial arrhythmia (HP:0001692) | 1.55659600 |
| 100 | Exercise intolerance (HP:0003546) | 1.55277790 |
| 101 | Akinesia (HP:0002304) | 1.54608346 |
| 102 | Abnormal atrioventricular conduction (HP:0005150) | 1.52871959 |
| 103 | Testicular atrophy (HP:0000029) | 1.52356982 |
| 104 | Palpitations (HP:0001962) | 1.51444976 |
| 105 | Thin ribs (HP:0000883) | 1.51107107 |
| 106 | Tarsal synostosis (HP:0008368) | 1.50739135 |
| 107 | Adducted thumb (HP:0001181) | 1.50583086 |
| 108 | Steppage gait (HP:0003376) | 1.39547682 |
| 109 | Oligomenorrhea (HP:0000876) | 1.39281930 |
| 110 | Pterygium (HP:0001059) | 1.39173587 |
| 111 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.38355687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 9.58367215 |
| 2 | TTN | 5.81143496 |
| 3 | PHKG1 | 4.36883167 |
| 4 | PHKG2 | 4.36883167 |
| 5 | PIK3CG | 4.26747335 |
| 6 | ZAK | 3.43163703 |
| 7 | NME1 | 3.28505698 |
| 8 | MUSK | 2.56813058 |
| 9 | MAP2K3 | 2.29047702 |
| 10 | PINK1 | 2.21928143 |
| 11 | PDK4 | 2.13501160 |
| 12 | PDK3 | 2.13501160 |
| 13 | NEK1 | 1.83395720 |
| 14 | DMPK | 1.71670309 |
| 15 | IRAK3 | 1.70968699 |
| 16 | MAP3K7 | 1.58817439 |
| 17 | PIK3CA | 1.57108008 |
| 18 | MAPK12 | 1.41849491 |
| 19 | PDK2 | 1.41735926 |
| 20 | EEF2K | 1.41050793 |
| 21 | TRIB3 | 1.37830151 |
| 22 | BCKDK | 1.36442053 |
| 23 | STK24 | 1.25280877 |
| 24 | MAP2K6 | 1.14807294 |
| 25 | TIE1 | 1.06666695 |
| 26 | TRPM7 | 0.98970239 |
| 27 | MAPKAPK3 | 0.87658563 |
| 28 | MAP3K3 | 0.86425106 |
| 29 | STK38L | 0.83257801 |
| 30 | NEK9 | 0.82882771 |
| 31 | MAP2K4 | 0.81844697 |
| 32 | AKT2 | 0.78570025 |
| 33 | TAOK2 | 0.78373068 |
| 34 | PKN2 | 0.76345760 |
| 35 | ERBB3 | 0.68123992 |
| 36 | PRKAA1 | 0.67124249 |
| 37 | CAMK2G | 0.60638293 |
| 38 | PRKAA2 | 0.60418666 |
| 39 | INSRR | 0.57767371 |
| 40 | MAP3K13 | 0.57472735 |
| 41 | DYRK1B | 0.57193718 |
| 42 | PKN1 | 0.56869274 |
| 43 | MAPK11 | 0.54299275 |
| 44 | IRAK4 | 0.53374756 |
| 45 | MAP3K10 | 0.51382067 |
| 46 | ILK | 0.49831343 |
| 47 | MOS | 0.46890005 |
| 48 | PLK4 | 0.45705332 |
| 49 | KSR2 | 0.44894984 |
| 50 | MYLK | 0.44079802 |
| 51 | MAP3K5 | 0.42578439 |
| 52 | LATS1 | 0.39611570 |
| 53 | CAMK1 | 0.39405488 |
| 54 | CAMK2B | 0.38523734 |
| 55 | TTK | 0.37942221 |
| 56 | ROCK1 | 0.36628434 |
| 57 | MAPK7 | 0.36259106 |
| 58 | CAMK2D | 0.36080979 |
| 59 | PRPF4B | 0.36061506 |
| 60 | ICK | 0.35154540 |
| 61 | LATS2 | 0.35148204 |
| 62 | MARK1 | 0.30944365 |
| 63 | RPS6KB1 | 0.30325208 |
| 64 | RPS6KB2 | 0.29913936 |
| 65 | EPHB1 | 0.29822632 |
| 66 | MAPK13 | 0.28661536 |
| 67 | MAP3K11 | 0.27673189 |
| 68 | PRKG1 | 0.27658150 |
| 69 | MARK2 | 0.27225781 |
| 70 | SGK1 | 0.26055840 |
| 71 | PRKACB | 0.25376117 |
| 72 | EPHA2 | 0.24321059 |
| 73 | IRAK1 | 0.23238512 |
| 74 | GRK7 | 0.21982048 |
| 75 | PIM2 | 0.21688646 |
| 76 | MAPK4 | 0.21310456 |
| 77 | LIMK1 | 0.21287415 |
| 78 | PRKACA | 0.21006582 |
| 79 | DDR2 | 0.20834263 |
| 80 | MAP3K1 | 0.20579398 |
| 81 | CCNB1 | 0.18266018 |
| 82 | TSSK6 | 0.18131579 |
| 83 | PRKD1 | 0.17989758 |
| 84 | TBK1 | 0.17638784 |
| 85 | RIPK1 | 0.17232070 |
| 86 | NLK | 0.17096205 |
| 87 | STK38 | 0.16582601 |
| 88 | MAP2K1 | 0.15243715 |
| 89 | SGK3 | 0.15161387 |
| 90 | IRAK2 | 0.14909065 |
| 91 | FGFR3 | 0.14715619 |
| 92 | CDK19 | 0.14621791 |
| 93 | STK11 | 0.14163841 |
| 94 | MTOR | 0.14143395 |
| 95 | ARAF | 0.12172701 |
| 96 | AKT3 | 0.11888110 |
| 97 | CAMK2A | 0.11835952 |
| 98 | PDK1 | 0.11336810 |
| 99 | RPS6KA3 | 0.11057769 |
| 100 | SGK223 | 0.10908304 |
| 101 | SGK494 | 0.10908304 |
| 102 | SGK2 | 0.10277026 |
| 103 | FLT3 | 0.09368094 |
| 104 | RAF1 | 0.08829276 |
| 105 | DAPK2 | 0.08471844 |
| 106 | SIK1 | 0.08079907 |
| 107 | ROCK2 | 0.07539596 |
| 108 | MAP3K6 | 0.07475234 |
| 109 | LMTK2 | 0.07464769 |
| 110 | PTK2B | 0.07313154 |
| 111 | TGFBR2 | 0.06853739 |
| 112 | FGFR4 | 0.06175494 |
| 113 | ZAP70 | 0.05908170 |
| 114 | NME2 | 0.05244412 |
| 115 | MAPK8 | 0.04584101 |
| 116 | KSR1 | 0.03933089 |
| 117 | EPHA3 | 0.03582286 |
| 118 | RPS6KA2 | 0.03539969 |
| 119 | EIF2AK2 | 0.02778258 |
| 120 | CAMK4 | 0.02776989 |
| 121 | STK3 | 0.02446486 |
| 122 | RPS6KA6 | 0.02395974 |
| 123 | PRKG2 | 0.02315548 |
| 124 | PTK6 | 0.02209221 |
| 125 | RPS6KA1 | 0.02201532 |
| 126 | CDC42BPA | 0.01866659 |
| 127 | MAPKAPK2 | 0.00151860 |
| 128 | TYK2 | -0.0267030 |
| 129 | PRKACG | -0.0256334 |
| 130 | TAOK1 | -0.0176620 |
| 131 | PDPK1 | -0.0127256 |
| 132 | RPS6KL1 | -0.0079119 |
| 133 | RPS6KC1 | -0.0079119 |
| 134 | MAPK10 | -0.0046345 |
| 135 | JAK1 | -0.0011862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 5.02159955 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.92177525 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.41918323 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.33416669 |
| 5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 4.15790913 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.42940558 |
| 7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.71036383 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.58426124 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.52865065 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.38441297 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.13284650 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.11384281 |
| 13 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.95036290 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.84308245 |
| 15 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.81387552 |
| 16 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.77487831 |
| 17 | Circadian rhythm_Homo sapiens_hsa04710 | 1.75376805 |
| 18 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.69478485 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.67190978 |
| 20 | Galactose metabolism_Homo sapiens_hsa00052 | 1.66857852 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.66581127 |
| 22 | Insulin resistance_Homo sapiens_hsa04931 | 1.60787666 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.60275011 |
| 24 | Huntingtons disease_Homo sapiens_hsa05016 | 1.55068788 |
| 25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.51832360 |
| 26 | Tight junction_Homo sapiens_hsa04530 | 1.48501702 |
| 27 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.47587459 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.44257497 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.41404200 |
| 30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.37655831 |
| 31 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.25430312 |
| 32 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.14727604 |
| 33 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.14694225 |
| 34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13570614 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.13568279 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.05499342 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.02312029 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.01987288 |
| 39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01388915 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99632021 |
| 41 | Focal adhesion_Homo sapiens_hsa04510 | 0.99290447 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90782341 |
| 43 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.88124888 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85952691 |
| 45 | Long-term potentiation_Homo sapiens_hsa04720 | 0.82777269 |
| 46 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.82774128 |
| 47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81513163 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.77456571 |
| 49 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72524103 |
| 50 | Salivary secretion_Homo sapiens_hsa04970 | 0.69102735 |
| 51 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.68397030 |
| 52 | Circadian entrainment_Homo sapiens_hsa04713 | 0.68271691 |
| 53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.67304405 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65952981 |
| 55 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64773355 |
| 56 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59590898 |
| 57 | Proteasome_Homo sapiens_hsa03050 | 0.54897618 |
| 58 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54400688 |
| 59 | Purine metabolism_Homo sapiens_hsa00230 | 0.50810868 |
| 60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.50567896 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49850683 |
| 62 | Adherens junction_Homo sapiens_hsa04520 | 0.47653166 |
| 63 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47295419 |
| 64 | Long-term depression_Homo sapiens_hsa04730 | 0.47147913 |
| 65 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.45508491 |
| 66 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.44761815 |
| 67 | Glioma_Homo sapiens_hsa05214 | 0.44333768 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44173862 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43975003 |
| 70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42484859 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41946365 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41634097 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41319286 |
| 74 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.40165946 |
| 75 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39818560 |
| 76 | Phototransduction_Homo sapiens_hsa04744 | 0.39710903 |
| 77 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.38968939 |
| 78 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38420608 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38333844 |
| 80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.36592590 |
| 81 | Lysine degradation_Homo sapiens_hsa00310 | 0.35204120 |
| 82 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35059671 |
| 83 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.34269516 |
| 84 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.33370472 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.32548142 |
| 86 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.31689973 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.31625210 |
| 88 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.31368418 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.29152511 |
| 90 | Melanogenesis_Homo sapiens_hsa04916 | 0.28946815 |
| 91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28862456 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28158934 |
| 93 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.27959773 |
| 94 | Insulin secretion_Homo sapiens_hsa04911 | 0.27583292 |
| 95 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.24241840 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.24103706 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.22400754 |
| 98 | Bile secretion_Homo sapiens_hsa04976 | 0.20060500 |
| 99 | Olfactory transduction_Homo sapiens_hsa04740 | 0.17158707 |
| 100 | Renin secretion_Homo sapiens_hsa04924 | 0.16902964 |
| 101 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.16616462 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.16171228 |
| 103 | RNA degradation_Homo sapiens_hsa03018 | 0.16056061 |
| 104 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.14632007 |
| 105 | Peroxisome_Homo sapiens_hsa04146 | 0.14461243 |
| 106 | Endometrial cancer_Homo sapiens_hsa05213 | 0.14104210 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.13904061 |
| 108 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.13584621 |
| 109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.13324445 |
| 110 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.11931985 |
| 111 | Legionellosis_Homo sapiens_hsa05134 | 0.11603651 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.09207079 |
| 113 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.08894461 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.08056274 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.07825408 |
| 116 | Leishmaniasis_Homo sapiens_hsa05140 | 0.07221183 |
| 117 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.06996250 |
| 118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.06821099 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.06798031 |
| 120 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.04310441 |
| 121 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.03694462 |
| 122 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.02601518 |
| 123 | HTLV-I infection_Homo sapiens_hsa05166 | 0.01810772 |
| 124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.00652946 |
| 125 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.00481745 |
| 126 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | -0.0269424 |
| 127 | Salmonella infection_Homo sapiens_hsa05132 | -0.0258683 |
| 128 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.0061144 |
| 129 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0053464 |

